Entity

Time filter

Source Type

Paris, France

The present invention relates to compositions and methods for the treatment of Parkinsons disease and related disorders. More specifically, the present invention relates to novel combinatorial therapies of Parkinsons disease and related disorders targeting the alpha-synuclein aggregation network. In particular, the invention relates to compounds which, alone or in combination(s), can effectively protect neuronal cells from alpha-synuclein aggregates. The invention also relates to methods of producing a drug or a drug combination for treating Parkinsons disease and to methods of treating Parkinsons disease or a related disorder.


Patent
Pharnext | Date: 2014-08-29

The present invention relates to compositions and methods for the treatment of amyotrophic lateral sclerosis. More specifically, the present invention relates to novel combinatorial therapies for treating amyotrophic lateral sclerosis or a related disorder.


Compositions and methods for the treatment of Charcot-Marie-Tooth disease and related disorders. Also provided are combination therapies for treating this disease by decreasing PMP22 expression in a subject.


Patent
Pharnext | Date: 2014-08-18

The present invention relates to compositions and methods for the treatment of Alzheimers disease and related disorders. More specifically, the present invention relates to novel combinatorial therapies of Alzheimers disease and related disorders. In particular, the invention concerns compounds which, alone or in combination(s), can effectively modulate synapse function and/or angiogenesis and/or cell stress response. The invention also relates to methods of producing a drug or a drug combination for treating Alzheimers disease and to methods of treating Alzheimers disease or a related disorder.


Patent
Pharnext | Date: 2014-02-24

The present invention relates to compositions and methods for the treatment of the Charcot-Marie-Tooth disease and related disorders.

Discover hidden collaborations